Administrative Claims Databases in Rare Bone Diseases: Opportunities, Challenges, and Future Directions

Rare bone diseases (RBD) are heterogeneous conditions associated with substantial morbidity and healthcare burden. While registries enable deep phenotyping, they often lack population-level capture and insight into real-world healthcare utilization. We conducted a scoping review to evaluate how administrative claims databases have been used in RBD research and to characterize their methodological strengths and limitations. Following PRISMA-ScR guidelines, we searched PubMed/MEDLINE with complementary screening of Embase records for English-language studies using administrative or health insurance claims databases in RBD, without year restriction. The final search was completed on February 4, 2026. Data were charted using a standardized framework capturing study characteristics, database type, design, case definitions, validation procedures, and outcomes across predefined impact domains. Twenty-nine studies (2006–2026) were included, with most published since 2023 (21/29, 72%). The literature was predominantly concentrated on osteogenesis imperfecta (11/29, 38%), followed by achondroplasia and Paget’s disease (5/29 each, 17%). Most studies were conducted in the United States (17/29, 59%) and used retrospective cohort designs, frequently with matched comparator groups (16/29, 55%). Data sources included public population-based systems (15/29, 52%), private claims databases (12/29, 41%), and mixed public–private data sources (2/29, 7%). Health system utilization and costs were the most frequently examined outcomes (16/29, 55%), followed by disease burden and complications (15/29, 52%). Methodologically, most studies relied on ICD-based case ascertainment, frequently using single-code definitions (20/29, 69%), while registry linkage and external validation of case ascertainment remained uncommon (4/29, 14% each), limiting phenotype validity and comparability across studies. Claims databases provide scalable insights into healthcare utilization and disease burden in RBD but are constrained by frequent unvalidated phenotyping and limited clinical granularity. Future studies should prioritize validated and standardized case-identification algorithms, robust validation strategies, and integration with complementary real-world data sources such as registries and electronic health records.

Authors

Institutions

Publication Details

Journal
JBMR Plus
Published
2026-11-18
DOI
https://doi.org/10.1093/jbmrpl/ziag186
Primary Topic
Medical Coding and Health Information
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Administrative Claims Databases in Rare Bone Diseases: Opportunities, Challenges, and Future Directions

Julien Paccou, Emmanuel Chazard, Cécile Philippoteaux, Antoine Lamer et al.
2 links
JBMR Plus
Medical Coding and Health Information
article

Administrative Claims Databases in Rare Bone Diseases: Opportunities, Challenges, and Future Directions

Julien Paccou, Emmanuel Chazard, Cécile Philippoteaux, Antoine Lamer, Suzanne N. Morin, Laëtitia Michou
article en

Abstract

Rare bone diseases (RBD) are heterogeneous conditions associated with substantial morbidity and healthcare burden. While registries enable deep phenotyping, they often lack population-level capture and insight into real-world healthcare utilization. We conducted a scoping review to evaluate how administrative claims databases have been used in RBD research and to characterize their methodological strengths and limitations. Following PRISMA-ScR guidelines, we searched PubMed/MEDLINE with complementary screening of Embase records for English-language studies using administrative or health insurance claims databases in RBD, without year restriction. The final search was completed on February 4, 2026. Data were charted using a standardized framework capturing study characteristics, database type, design, case definitions, validation procedures, and outcomes across predefined impact domains. Twenty-nine studies (2006–2026) were included, with most published since 2023 (21/29, 72%). The literature was predominantly concentrated on osteogenesis imperfecta (11/29, 38%), followed by achondroplasia and Paget’s disease (5/29 each, 17%). Most studies were conducted in the United States (17/29, 59%) and used retrospective cohort designs, frequently with matched comparator groups (16/29, 55%). Data sources included public population-based systems (15/29, 52%), private claims databases (12/29, 41%), and mixed public–private data sources (2/29, 7%). Health system utilization and costs were the most frequently examined outcomes (16/29, 55%), followed by disease burden and complications (15/29, 52%). Methodologically, most studies relied on ICD-based case ascertainment, frequently using single-code definitions (20/29, 69%), while registry linkage and external validation of case ascertainment remained uncommon (4/29, 14% each), limiting phenotype validity and comparability across studies. Claims databases provide scalable insights into healthcare utilization and disease burden in RBD but are constrained by frequent unvalidated phenotyping and limited clinical granularity. Future studies should prioritize validated and standardized case-identification algorithms, robust validation strategies, and integration with complementary real-world data sources such as registries and electronic health records.

JBMR Plus
Université de Lille (FR), McGill University Health Centre (CA), Centre Hospitalier Universitaire de Lille (FR), Lille’s Cardiology Hospital (FR), Université Laval (CA), Adiposité Médullaire et Os (FR), Evaluation des technologies de santé et des pratiques médicales (FR), Centre de recherche du CHU de Québec-Université Laval (CA), McGill University (CA)
Good health and well-being
Medical Coding and Health Information
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon